• Atea raises $215M to support midphase COVID-19 antiviral trial 

    4 days ago - By Fierce Biotech

    Atea raises $215M to support midphase COVID-19 antiviral trial ntaylor
    Wed, 05/20/2020 - 09:41
    Read more ...

     

  • It's too soon to assume success for Moderna's COVID-19 vaccine: analyst

    4 days ago - By Fierce Biotech

    It's too soon to assume success for Moderna's COVID-19 vaccine: analyst arlene.weintraub
    Wed, 05/20/2020 - 10:20
    Read more ...